Literature DB >> 3175752

TLSO treatment of idiopathic scoliosis. An analysis of the Wilmington jacket.

G A Hanks1, B Zimmer, J Nogi.   

Abstract

A retrospective study of one hundred female patients treated for idiopathic scoliosis using an underarm plastic thoracolumbar-sacral orthosis (TLSO) jacket was undertaken. The purpose of the study was to evaluate the efficacy of the Wilmington jacket, to search for clinical variables which could statistically predict success, and to evaluate preliminary results of parttime bracing in 25 patients. The following parameters were statistically evaluated by multiple regression analysis: age, sex, curve location, number of vertebrae in curve, Cobb angle, maturity (Risser sign, menarche), curve flexibility, and hours in the jacket. The overall success rate was 81%, and onset of menarche and Risser sign were statistically significant prognostic variables. Ten patients (10%) underwent posterior spinal fusion for curve progression. Bracing with an underarm scoliosis jacket is a successful method of treatment of idiopathic scoliosis in the immature spine. We do not recommend brace treatment for postmenarchal patients or patients with a Risser sign of Grade 1 or greater until curve progression has been observed. Furthermore, the Wilmington jacket appears to give similar results for part-time brace wearers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3175752

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Design of the Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST).

Authors:  Stuart L Weinstein; Lori A Dolan; James G Wright; Matthew B Dobbs
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-01       Impact factor: 3.468

2.  Asymmetric evolution of anterior chest wall blood supply in female adolescents with progressive right-convex thoracic idiopathic scoliosis.

Authors:  Panagiotis Iliopoulos; Panagiotis Korovessis; Georgios Koureas; Spyridon Zacharatos; Panagiotis Stergiou
Journal:  Eur Spine J       Date:  2007-02-09       Impact factor: 3.134

3.  [Compliance as a prognostic factor in the treatment of idiopathic scoliosis].

Authors:  J Seifert; A Selle; C Flieger; K P Günther
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

4.  Predictive factors for brace treatment outcome in adolescent idiopathic scoliosis: a best-evidence synthesis.

Authors:  Manon van den Bogaart; Barend J van Royen; Tsjitske M Haanstra; Marinus de Kleuver; Sayf S A Faraj
Journal:  Eur Spine J       Date:  2019-01-03       Impact factor: 3.134

5.  Preference assessment of recruitment into a randomized trial for adolescent idiopathic scoliosis.

Authors:  Lori A Dolan; Vani Sabesan; Stuart L Weinstein; Kevin F Spratt
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

6.  Rib-vertebral angle measurements predict brace treatment outcome in Risser grade 0 and premenarchal girls with adolescent idiopathic scoliosis.

Authors:  Xu Sun; Qi Ding; Shifu Sha; Saihu Mao; Feng Zhu; Zezhang Zhu; Bangping Qian; Bin Wang; Jack C Y Cheng; Yong Qiu
Journal:  Eur Spine J       Date:  2016-01-23       Impact factor: 3.134

7.  Bracing In The Treatment Of Adolescent Idiopathic Scoliosis: Evidence To Date.

Authors:  Nikos Karavidas
Journal:  Adolesc Health Med Ther       Date:  2019-10-08

8.  Brace treatment for patients with scoliosis: State of the art.

Authors:  Hans-Rudolf Weiss; Tuğba Kuru Çolak; Manuel Lay; Maksym Borysov
Journal:  S Afr J Physiother       Date:  2021-10-26

9.  Clinical effect of continuous corrective force delivery in the non-operative treatment of idiopathic scoliosis: a prospective cohort study of the TriaC-brace.

Authors:  Gerben J Bulthuis; Albert G Veldhuizen; Gert Nijenbanning
Journal:  Eur Spine J       Date:  2007-10-10       Impact factor: 3.134

Review 10.  The Effectiveness of Different Concepts of Bracing in Adolescent Idiopathic Scoliosis (AIS): A Systematic Review and Meta-Analysis.

Authors:  Lorenzo Costa; Tom P C Schlosser; Hanad Jimale; Jelle F Homans; Moyo C Kruyt; René M Castelein
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.